SG10201710218RA - Sc-beta cells and compositions and methods for generating the same - Google Patents
Sc-beta cells and compositions and methods for generating the sameInfo
- Publication number
- SG10201710218RA SG10201710218RA SG10201710218RA SG10201710218RA SG10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- generating
- methods
- same
- beta cells
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/375—Thyroid stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/22—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361833898P | 2013-06-11 | 2013-06-11 | |
US201461972212P | 2014-03-28 | 2014-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201710218RA true SG10201710218RA (en) | 2018-01-30 |
Family
ID=52022750
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201510176VA SG11201510176VA (en) | 2013-06-11 | 2014-06-11 | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
SG10201710218RA SG10201710218RA (en) | 2013-06-11 | 2014-06-11 | Sc-beta cells and compositions and methods for generating the same |
SG11201510177WA SG11201510177WA (en) | 2013-06-11 | 2014-06-11 | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201510176VA SG11201510176VA (en) | 2013-06-11 | 2014-06-11 | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201510177WA SG11201510177WA (en) | 2013-06-11 | 2014-06-11 | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
Country Status (17)
Country | Link |
---|---|
US (13) | US20170029778A1 (en) |
EP (3) | EP3008170A4 (en) |
JP (6) | JP6514689B2 (en) |
KR (12) | KR102232650B1 (en) |
CN (4) | CN112226402A (en) |
AU (6) | AU2014278178B2 (en) |
BR (2) | BR112015030972A8 (en) |
CA (2) | CA2915088A1 (en) |
DE (2) | DE202014011287U1 (en) |
DK (1) | DK3008168T3 (en) |
GB (3) | GB2549822B (en) |
HK (1) | HK1257187B (en) |
MX (2) | MX2015017103A (en) |
PH (1) | PH12015502767A1 (en) |
RU (2) | RU2016100219A (en) |
SG (3) | SG11201510176VA (en) |
WO (2) | WO2014201167A1 (en) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2185693B1 (en) | 2007-07-31 | 2019-07-03 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
MX2010005805A (en) | 2007-11-27 | 2010-06-09 | Lifescan Inc | Differentiation of human embryonic stem cells. |
BR112014015417A8 (en) | 2011-12-22 | 2017-07-04 | Janssen Biotech Inc | differentiation of human embryonic stem cells into single hormone insulin positive cells |
CA2896658C (en) | 2012-12-31 | 2021-06-22 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators |
WO2014168973A2 (en) * | 2013-04-08 | 2014-10-16 | President And Fellows Of Harvard College | Methods and compositions for rejuvenating skeletal muscle stem cells |
KR102232650B1 (en) | 2013-06-11 | 2021-03-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
EP3954759A1 (en) | 2014-05-16 | 2022-02-16 | Janssen Biotech, Inc. | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
US10443042B2 (en) | 2014-12-18 | 2019-10-15 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof |
US20160175363A1 (en) * | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Methods for generating stem cell-derived beta cells and uses thereof |
EP3234110B1 (en) | 2014-12-18 | 2024-02-28 | President and Fellows of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED ß CELLS AND USES THEREOF |
US10253298B2 (en) | 2014-12-18 | 2019-04-09 | President And Fellows Of Harvard College | Methods for generating stem cell-derived beta cells and methods of use thereof |
US10196613B2 (en) | 2014-12-19 | 2019-02-05 | Regeneron Pharmaceuticals, Inc. | Stem cells for modeling type 2 diabetes |
US10975355B2 (en) | 2015-04-23 | 2021-04-13 | The Regents Of The University Of California | Controlled induction of human pancreatic progenitors produces functional beta-like cells |
WO2016170069A1 (en) * | 2015-04-24 | 2016-10-27 | University Of Copenhagen | Isolation of bona fide pancreatic progenitor cells |
ES2856872T3 (en) * | 2015-04-24 | 2021-09-28 | Univ Copenhagen | Procedure for the production of insulin-producing cells |
US11332716B2 (en) | 2015-07-27 | 2022-05-17 | The Regents Of The University Of California | Methods and compositions for producing pancreatic beta cells |
US11499140B2 (en) * | 2015-10-29 | 2022-11-15 | Juntendo Educational Foundation | Method for producing pancreatic endocrine cells, and transdifferentiation agent |
WO2017083555A1 (en) | 2015-11-10 | 2017-05-18 | City Of Hope | Conditioning regimens and methods for inducing mixed chimerism |
WO2017116569A1 (en) * | 2015-12-31 | 2017-07-06 | City Of Hope | Methods for treating diabetes |
IL285371B (en) * | 2016-01-06 | 2022-07-01 | Harvard College | Treatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis |
US11473061B2 (en) | 2016-02-01 | 2022-10-18 | Cedars-Sinai Medical Center | Systems and methods for growth of intestinal cells in microfluidic devices |
US11274280B2 (en) * | 2016-02-24 | 2022-03-15 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
JP2019507609A (en) * | 2016-03-02 | 2019-03-22 | フリークエンシー セラピューティクス インコーポレイテッド | Methods for controlled proliferation of vestibular stem cells / generation of inner ear hair cells using WNT and TGF-beta inhibition |
US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
MA45329A (en) | 2016-04-08 | 2019-02-13 | Univ California | PRODUCTION OF FULLY FUNCTIONAL MATURE BETA CELLS FROM HUMAN PANCREATIC PROGENITORS |
US20190151371A1 (en) * | 2016-06-09 | 2019-05-23 | Georgetown University | Process for continuous cell culture of islet cells |
MA45502A (en) * | 2016-06-21 | 2019-04-24 | Janssen Biotech Inc | GENERATION OF FUNCTIONAL BETA CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS WITH GLUCOSE-DEPENDENT MITOCHONDRIAL RESPIRATION AND TWO-PHASE INSULIN SECRETION RESPONSE |
CN109963938A (en) * | 2016-11-16 | 2019-07-02 | 美国绿阳生物技术及医药公司 | Pass through stem cell induction pancreatic beta cell with RNA |
WO2018140647A1 (en) | 2017-01-25 | 2018-08-02 | Cedars-Sinai Medical Center | In vitro induction of mammary-like differentiation from human pluripotent stem cells |
KR101745297B1 (en) | 2017-02-02 | 2017-06-09 | 경북대학교 산학협력단 | Composition for diagnosis of obesity and uses thereof |
US11767513B2 (en) | 2017-03-14 | 2023-09-26 | Cedars-Sinai Medical Center | Neuromuscular junction |
WO2018176001A2 (en) | 2017-03-24 | 2018-09-27 | Cedars-Sinai Medical Center | Methods and compositions for production of fallopian tube epithelium |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
IL308120A (en) | 2017-06-14 | 2023-12-01 | Vertex Pharma | Devices and methods for delivering therapeutics |
US20210355448A1 (en) * | 2017-06-26 | 2021-11-18 | City Of Hope | Methods of islet cell culture |
US10391156B2 (en) | 2017-07-12 | 2019-08-27 | Viacyte, Inc. | University donor cells and related methods |
WO2019018818A1 (en) * | 2017-07-21 | 2019-01-24 | Semma Therapeutics, Inc. | Re-aggregation of stem cell-derived pancreatic beta cells |
CA2983845C (en) | 2017-10-26 | 2024-01-30 | University Of Copenhagen | Generation of glucose-responsive beta cells |
IL305391A (en) * | 2017-11-15 | 2023-10-01 | Vertex Pharma | Islet cell manufacturing compositions and methods of use |
CA3092842A1 (en) * | 2018-03-02 | 2019-09-06 | Vertex Pharmaceuticals Incorporated | Methods of enhancing stem cell differentiation into beta cells |
WO2019183597A1 (en) * | 2018-03-23 | 2019-09-26 | Cedars-Sinai Medical Center | Methods of use of islet cells |
US20210071146A1 (en) * | 2018-05-11 | 2021-03-11 | Cornell University | Method of differentiation of human pluripotent stem cells to monohormonal cells |
EP3833365A4 (en) | 2018-08-10 | 2022-05-11 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
CA3109647A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating jag-1 |
US11617745B2 (en) | 2018-08-17 | 2023-04-04 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating FOXO |
AU2018439389A1 (en) * | 2018-08-30 | 2021-02-18 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
US10724052B2 (en) | 2018-09-07 | 2020-07-28 | Crispr Therapeutics Ag | Universal donor cells |
AU2019342197A1 (en) | 2018-09-21 | 2021-04-15 | President And Fellows Of Harvard College | Methods and compositions for treating diabetes, and methods for enriching mRNA coding for secreted proteins |
AU2019347876A1 (en) * | 2018-09-28 | 2021-05-13 | Memorial Sloan-Kettering Cancer Center | Stem cell-derived human microglial cells, methods of making and methods of use |
WO2020080550A1 (en) * | 2018-10-15 | 2020-04-23 | Cynity株式会社 | Method for producing stem/precursor cells, by using low molecular weight compound, from cells derived from endodermal tissue or organ |
KR102115960B1 (en) * | 2018-11-28 | 2020-05-27 | 송미연 | A method of differentiating human mesenchymal stem cells to thyrotropic cells |
WO2020206046A1 (en) | 2019-04-01 | 2020-10-08 | The Broad Institute, Inc. | Methods and compositions for cell therapy |
KR102167257B1 (en) * | 2019-05-28 | 2020-10-19 | 부산대학교 산학협력단 | Method of promoting differentiation of stem cells into mature cardiomyocytes using tomatidine |
JP2022534545A (en) | 2019-05-31 | 2022-08-01 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | biocompatible membrane composite |
CA3139585C (en) | 2019-05-31 | 2024-01-23 | W. L. Gore & Associates, Inc. | A biocompatible membrane composite |
CA3139591C (en) | 2019-05-31 | 2024-01-16 | Timothy M. BRUHN | A biocompatible membrane composite |
CN114401752B (en) | 2019-05-31 | 2023-04-04 | W.L.戈尔及同仁股份有限公司 | Cell encapsulation device with controlled oxygen diffusion distance |
WO2020247954A1 (en) * | 2019-06-06 | 2020-12-10 | President And Fellows Of Harvard College | Compositions and methods for maturing stem cell-derived beta cells |
WO2020264072A1 (en) | 2019-06-25 | 2020-12-30 | Semma Therapeutics, Inc. | Enhanced differentiation of beta cells |
WO2021030424A1 (en) * | 2019-08-13 | 2021-02-18 | Semma Therapeutics, Inc. | Pancreatic differentiation |
US10740609B1 (en) * | 2019-08-30 | 2020-08-11 | Numerica Corporation | System and method for space object detection in daytime sky images |
AU2020341186A1 (en) | 2019-09-05 | 2022-03-03 | Crispr Therapeutics Ag | Universal donor cells |
MX2022002663A (en) | 2019-09-05 | 2022-04-07 | Crispr Therapeutics Ag | Universal donor cells. |
WO2021072390A1 (en) * | 2019-10-10 | 2021-04-15 | The Regents Of The University Of Colorado, A Body Corporate | Use of entpd3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells |
US20230014430A1 (en) * | 2019-11-20 | 2023-01-19 | Washington University | Methods and Compositions for Generating Functionally Mature Beta Cells and Uses Thereof |
US11801304B2 (en) | 2020-02-19 | 2023-10-31 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof |
CN111269875B (en) * | 2020-03-24 | 2022-04-08 | 山东兴瑞生物科技有限公司 | Method for directionally differentiating into islet cells by using autoimmune cells |
WO2021212044A1 (en) * | 2020-04-16 | 2021-10-21 | Washington University | Methods and compositions for improving sc-beta cells or enhancing their utility |
US20220010282A1 (en) * | 2020-06-16 | 2022-01-13 | The Broad Institute, Inc. | Three-dimensional cell culture, devices, and use thereof |
EP4189066A2 (en) * | 2020-07-31 | 2023-06-07 | Vertex Pharmaceuticals Incorporated | In vitro differentiation of pancreatic endocrine cells |
KR20230146007A (en) | 2020-12-31 | 2023-10-18 | 크리스퍼 테라퓨틱스 아게 | universal donor cells |
CN112980771B (en) * | 2021-03-05 | 2023-12-19 | 贝康医学科技有限公司 | Method for preparing pancreatic beta cells and application thereof |
CN112961823B (en) * | 2021-03-19 | 2024-01-23 | 上海爱萨尔生物科技有限公司 | Culture solution for preparing islet beta cells by inducing directional differentiation of pluripotent stem cells |
CN113046299A (en) * | 2021-03-19 | 2021-06-29 | 上海爱萨尔生物科技有限公司 | Additive for preparing islet beta cells by inducing pluripotent stem cells to differentiate directionally |
CN112980774B (en) * | 2021-03-19 | 2022-04-01 | 上海爱萨尔生物科技有限公司 | Culture method for preparing islet beta cells by inducing pluripotent stem cells to differentiate directionally |
US20220403340A1 (en) * | 2021-06-11 | 2022-12-22 | Washington University | Media for cryopreserved cells and methods of making and using same |
US20220409855A1 (en) | 2021-06-29 | 2022-12-29 | Staffan Holmin | Methods of delivering cells and therapeutic agents to organs and extravascular sites |
WO2023048182A1 (en) | 2021-09-21 | 2023-03-30 | Okinawa Institute Of Science And Technology School Corporation | Platforms for drug tests against synucleinopathy using human brain organoids |
WO2023070019A1 (en) | 2021-10-21 | 2023-04-27 | Vertex Pharmaceuticals Incorporated | Hypoimmune cells |
WO2023072170A1 (en) * | 2021-10-28 | 2023-05-04 | Sunshine Lake Pharma Co., Ltd. | A METHOD FOR PROMOTING THE DIFFERENTIATION OF STEM CELLS INTO FUNCTIONALLY MATURE ISLET β CELLS AND USE THEREOF |
CA3232971A1 (en) | 2021-11-01 | 2023-05-04 | George Harb | Stem cell derived pancreatic islet differentiation |
WO2023097513A1 (en) * | 2021-11-30 | 2023-06-08 | Hangzhou Reprogenix Bioscience, Inc. | Method of generating functional islets from pluripotent stem cells |
WO2023150493A2 (en) * | 2022-02-01 | 2023-08-10 | Vertex Pharmaceuticals Incorporated | Cell therapy for diabetes |
WO2023199113A1 (en) | 2022-04-15 | 2023-10-19 | Smartcella Solutions Ab | COMPOSITIONS AND METHODS FOR EXOSOME-MEDIATED DELIVERY OF mRNA AGENTS |
WO2023235568A1 (en) * | 2022-06-03 | 2023-12-07 | Cornell University | Derivation of glucose-responsive insulin-secreting cells and organoids from human stomach cells and their use to treat diabetes |
Family Cites Families (166)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US130A (en) | 1837-02-16 | Improvement in metallic solutions for the preservation of timber | ||
US6774A (en) | 1849-10-09 | Improved jointed center-board | ||
US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
DE1570610C3 (en) | 1965-10-01 | 1974-08-01 | Bayer Ag, 5090 Leverkusen | Process for the production of poly-N-oxides |
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4391909A (en) | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
US4378016A (en) | 1981-07-15 | 1983-03-29 | Biotek, Inc. | Artificial endocrine gland containing hormone-producing cells |
US5425764A (en) | 1992-07-30 | 1995-06-20 | The University Of Toledo | Bioartificial pancreas |
US6469017B1 (en) | 1998-01-16 | 2002-10-22 | Cell Therapeutics, Inc. | Method of inhibiting interleukin-12 signaling |
US7018419B2 (en) | 1994-05-20 | 2006-03-28 | Spielberg Theodore E | Microporous encapsulated endocrine cell disks, biconcave disks and multidimpled chambers for hormonal replacement |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
EP0822834A4 (en) * | 1995-04-07 | 2002-09-18 | Einstein Coll Med | Recombinant (beta)-cell and uses thereof |
US6187991B1 (en) | 1995-05-23 | 2001-02-13 | Pfizer Inc | Transgenic animal models for type II diabetes mellitus |
WO1997030778A1 (en) | 1996-02-23 | 1997-08-28 | Circle Biomedical, Inc. | Novel artificial pancreas |
US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
WO1998014592A2 (en) | 1996-10-01 | 1998-04-09 | Geron Corporation | Telomerase reverse transcriptase |
US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
CA2277278A1 (en) | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
US6090622A (en) | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
AU1197699A (en) | 1997-10-23 | 1999-05-10 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells |
US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
CA2397292A1 (en) | 2000-01-14 | 2001-07-19 | Bresagen Limited | Cell production |
GB0005251D0 (en) | 2000-03-03 | 2000-04-26 | Merck Sharp & Dohme | Therapeutic compounds |
US6436704B1 (en) | 2000-04-10 | 2002-08-20 | Raven Biotechnologies, Inc. | Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
GB2379447B (en) | 2000-05-17 | 2004-12-29 | Geron Corp | Neural progenitor cell populations |
US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
US6906810B2 (en) | 2000-07-13 | 2005-06-14 | Morgan Guaranty Trust Company | Method and system for allowing an on-line user to selectively customize a document for printing in a single batch process |
US7163918B2 (en) | 2000-08-22 | 2007-01-16 | New River Pharmaceuticals Inc. | Iodothyronine compositions |
US6905875B2 (en) | 2000-10-12 | 2005-06-14 | National University Of Singapore | Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells |
CA2425356C (en) | 2000-10-13 | 2015-10-06 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
US6576464B2 (en) | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
EP1366148A2 (en) | 2001-01-24 | 2003-12-03 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES | Differentiation of stem cells to pancreatic endocrine cells |
CA2447015A1 (en) | 2001-05-15 | 2002-11-21 | Rappaport Family Institute For Research In The Medical Sciences | Insulin producing cells derived from human embryonic stem cells |
CA2456981C (en) | 2001-08-06 | 2012-02-28 | Bresagen, Inc. | Alternative compositions and methods for the culture of stem cells |
US20030054331A1 (en) | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
JP2005506074A (en) | 2001-10-18 | 2005-03-03 | イクシオン・バイオテクノロジー・インコーポレーテッド | Conversion of hepatic stem and progenitor cells into functional pancreatic cells |
US20030077256A1 (en) | 2001-10-19 | 2003-04-24 | Paul Czernichow | Pancreas regeneration using embryonic pancreatic cells |
US7157278B2 (en) | 2001-12-04 | 2007-01-02 | Organogenesis, Inc. | Cultured cells from pancreatic islets |
EP2264146A1 (en) | 2001-12-07 | 2010-12-22 | Geron Corporation | Islet cells from human embryonic stem cells |
JP5364224B2 (en) | 2001-12-07 | 2013-12-11 | ジェロン・コーポレーション | Hematopoietic cells derived from human embryonic stem cells |
CA2469370C (en) | 2001-12-07 | 2014-07-08 | Macropore Biosurgery, Inc. | Adipose-derived cell processing unit |
US20060003446A1 (en) | 2002-05-17 | 2006-01-05 | Gordon Keller | Mesoderm and definitive endoderm cell populations |
BR0311360A (en) | 2002-05-28 | 2006-06-06 | Becton Dickinson Co | methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin producing cells |
AU2003240810A1 (en) | 2002-05-28 | 2003-12-12 | Becton, Dickinson And Company | Methods, compositions, and growth and differentiation factors for insulin-producing cells |
EP1567639A4 (en) | 2002-12-05 | 2005-12-21 | Technion Res & Dev Foundation | Cultured human pancreatic islets, and uses thereof |
AU2003300522A1 (en) | 2002-12-27 | 2004-07-22 | Bayer Healthcare Ag | 4-phenyl-pyrimido (4,5-b) indole derivatives |
US7172682B2 (en) | 2003-01-24 | 2007-02-06 | Rensselaer Polytechnic Institute | Enzyme immobilization for electroosmotic flow |
US20030224411A1 (en) | 2003-03-13 | 2003-12-04 | Stanton Lawrence W. | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
US7084246B2 (en) | 2003-04-17 | 2006-08-01 | Molecular Logix, Inc. | Epidermal growth factor agonists |
DK2722387T3 (en) | 2003-12-23 | 2020-01-20 | Viacyte Inc | Definitely endoderm |
US7541185B2 (en) | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
WO2007059007A2 (en) | 2005-11-14 | 2007-05-24 | Cythera, Inc. | Markers of definitive endoderm |
US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
US7625753B2 (en) | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
CA2558486A1 (en) | 2004-03-10 | 2005-09-22 | Alberto Hayek | Compositions and methods for growth of embryonic stem cells |
WO2005094374A2 (en) | 2004-03-30 | 2005-10-13 | The Regents Of The University Of California | Hydrazide-containing cftr inhibitor compounds and uses thereof |
KR20070029681A (en) | 2004-04-01 | 2007-03-14 | 위스콘신 얼럼나이 리서어치 화운데이션 | Differentiation of stem cells to endoderm and pancreatic lineage |
EP2377922B1 (en) | 2004-04-27 | 2020-04-08 | Viacyte, Inc. | PDX1 expressing endoderm |
EP1809739B1 (en) | 2004-07-13 | 2014-10-15 | Asterias Biotherapeutics, Inc. | Medium for growing human embryonic stem cells |
EP1791952A4 (en) | 2004-08-13 | 2008-06-11 | Univ Georgia Res Found | Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
US7517870B2 (en) | 2004-12-03 | 2009-04-14 | Fondazione Telethon | Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization |
EP1676574A3 (en) | 2004-12-30 | 2006-07-26 | Johnson & Johnson Vision Care, Inc. | Methods for promoting survival of transplanted tissues and cells |
AU2006210955A1 (en) | 2005-01-31 | 2006-08-10 | Es Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
GB2441488C (en) | 2005-06-22 | 2011-10-05 | Geron Corp | Suspension culture of human embryonic stem cells |
JP5560393B2 (en) | 2005-06-22 | 2014-07-23 | アステリアス バイオセラピューティクス インコーポレイテッド | Differentiation of primate pluripotent stem cells into cardiomyocyte lineage cells |
AU2006270066A1 (en) | 2005-07-19 | 2007-01-25 | University Of Tennessee Research Foundation | LPA2 receptor agonist inhibitors of CFTR |
WO2007051038A2 (en) | 2005-10-27 | 2007-05-03 | Cythera, Inc. | Pdx1-expressing dorsal and ventral foregut endoderm |
US20070142376A1 (en) | 2005-12-16 | 2007-06-21 | Alcon, Inc. | Control of intraocular pressure using alk5 modulation agents |
WO2007075807A2 (en) | 2005-12-20 | 2007-07-05 | Es Cell International Pte Ltd. | Methods for the directed differentiation of embryonic stem cell |
AU2007207434B2 (en) | 2006-01-20 | 2012-04-05 | Reneuron, Inc. | Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture |
WO2007088651A1 (en) | 2006-02-01 | 2007-08-09 | The University Of Tokyo | JOINT USE OF TGF-β SIGNAL INHIBITOR AND ANTITUMOR AGENT |
AU2007215140B2 (en) | 2006-02-13 | 2013-01-10 | The Board Of Trustees Of The Leland Stanford Junior University | Blockade of gamma-secretase activity to promote myelination by oligodendrocytes |
CA2643478C (en) | 2006-02-23 | 2019-06-18 | Novocell, Inc. | Compositions and methods useful for culturing differentiable cells |
US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
EP1999253B1 (en) | 2006-03-02 | 2019-05-22 | Viacyte, Inc. | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
US8247531B2 (en) | 2006-03-20 | 2012-08-21 | Cochran Jennifer R | Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor |
CA2650812C (en) | 2006-04-28 | 2017-12-12 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
US7964402B2 (en) | 2006-05-25 | 2011-06-21 | Sanford-Burnham Medical Research Institute | Methods for culture and production of single cell populations of human embryonic stem cells |
AU2007254766A1 (en) * | 2006-06-02 | 2007-12-13 | University Of Georgia Research Foundation, Inc. | Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems |
WO2007149182A2 (en) | 2006-06-19 | 2007-12-27 | Geron Corporation | Differentiation and enrichment of islet-like cells from human pluripotent stem cells |
AU2007277364B2 (en) | 2006-07-26 | 2010-08-12 | Viacyte, Inc. | Methods of producing pancreatic hormones |
WO2008027420A2 (en) | 2006-08-29 | 2008-03-06 | The University Of Akron | Implantable devices for producing insulin |
US9023984B2 (en) * | 2006-12-29 | 2015-05-05 | The Regents Of The University Of Colorado, A Body Corporate | Diagnostic and therapeutic target for autoimmune diseases and uses thereof |
CA2678870C (en) * | 2007-02-21 | 2017-07-11 | Sarl Endocells | Human pancreatic beta cell lines for diagnostic of diabetes |
US8283351B2 (en) | 2007-04-02 | 2012-10-09 | Institute For Oneworld Health | Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof |
CN101861386A (en) * | 2007-07-18 | 2010-10-13 | 生命扫描有限公司 | The differentiation of human embryo stem cell |
EP2185693B1 (en) | 2007-07-31 | 2019-07-03 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
WO2009019815A1 (en) | 2007-08-09 | 2009-02-12 | Kabushiki Kaisha Yakult Honsha | Novel γ-secretase inhibitor |
US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
US8623650B2 (en) | 2007-10-19 | 2014-01-07 | Viacyte, Inc. | Methods and compositions for feeder-free pluripotent stem cell media containing human serum |
MX2010005805A (en) | 2007-11-27 | 2010-06-09 | Lifescan Inc | Differentiation of human embryonic stem cells. |
SG154367A1 (en) | 2008-01-31 | 2009-08-28 | Es Cell Int Pte Ltd | Method of differentiating stem cells |
WO2009114180A1 (en) | 2008-03-13 | 2009-09-17 | The General Hospital Corporation | Inhibitors of the bmp signaling pathway |
US8338170B2 (en) | 2008-04-21 | 2012-12-25 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
DK2283117T3 (en) | 2008-04-21 | 2014-01-20 | Viacyte Inc | PROCEDURE FOR CLEANING PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS |
WO2009132083A2 (en) | 2008-04-22 | 2009-10-29 | President And Fellows Of Harvard College | Compositions and methods for promoting the generation of pdx1+ pancreatic cells |
US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
US20090298178A1 (en) * | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
ES2697798T3 (en) | 2008-06-30 | 2019-01-28 | Janssen Biotech Inc | Differentiation of pluripotent stem cells |
US9683215B2 (en) * | 2008-08-22 | 2017-06-20 | President And Fellows Of Harvard College | Methods of reprogramming cells |
US20120021519A1 (en) | 2008-09-19 | 2012-01-26 | Presidents And Fellows Of Harvard College | Efficient induction of pluripotent stem cells using small molecule compounds |
CA2742268C (en) * | 2008-10-31 | 2020-02-18 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
EP2350265B1 (en) * | 2008-10-31 | 2019-04-17 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
US8008075B2 (en) | 2008-11-04 | 2011-08-30 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods of differentiation thereof |
CA3229301A1 (en) | 2008-11-14 | 2010-05-20 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
ES2584053T3 (en) | 2008-11-20 | 2016-09-23 | Janssen Biotech, Inc. | Methods and compositions for cell binding and culture in flat substrates |
GB201111244D0 (en) | 2011-06-30 | 2011-08-17 | Konink Nl Akademie Van Wetenschappen Knaw | Culture media for stem cells |
WO2010091241A2 (en) | 2009-02-06 | 2010-08-12 | President And Fellows Of Harvard College | Compositions and methods for promoting the generation of definitive endoderm |
JP2012524073A (en) | 2009-04-17 | 2012-10-11 | スムマ ヘルス システムズ エルエルシー | Use of transforming growth factor-beta receptor inhibitors to inhibit eye scarring |
EP2421957B1 (en) * | 2009-04-22 | 2020-11-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
CN102741396B (en) | 2009-04-27 | 2017-10-20 | 威盛细胞有限公司 | Support the small molecule and its method of pluripotent cell growth |
WO2010135639A2 (en) * | 2009-05-21 | 2010-11-25 | Joslin Diabetes Center, Inc. | Compositions and methods for promoting beta cell maturity |
CA2768644A1 (en) * | 2009-07-20 | 2011-01-27 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
RU2540016C2 (en) | 2009-07-20 | 2015-01-27 | Янссен Байотек, Инк. | Differentiating human embryonic stem cells |
MX350966B (en) * | 2009-10-29 | 2017-09-26 | Janssen Biotech Inc | Pluripotent stem cells. |
KR101867369B1 (en) | 2009-12-23 | 2018-06-14 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells |
KR20130025375A (en) * | 2010-03-01 | 2013-03-11 | 얀센 바이오테크 인코포레이티드 | Methods for purifying cells derived from pluripotent stem cells |
CN105176930B (en) | 2010-03-31 | 2021-05-04 | 斯克里普斯研究所 | Reprogramming cells |
WO2011128897A1 (en) | 2010-04-12 | 2011-10-20 | Technion Research & Development Foundation Ltd. | Populations of pancreatic progenitor cells and methods of isolating and using same |
JP2013524836A (en) | 2010-04-25 | 2013-06-20 | マウント・シナイ・スクール・オブ・メディスン | Generation of anterior foregut endoderm from pluripotent cells |
CA2800610C (en) * | 2010-05-12 | 2019-09-24 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
SG187655A1 (en) * | 2010-08-09 | 2013-03-28 | Takeda Pharmaceutical | Method of producing pancreatic hormone-producing cells |
MX2013001673A (en) * | 2010-08-12 | 2013-03-25 | Janssen Biotech Inc | Treatment of diabetes with pancreatic endocrine precursor cells. |
GB201014169D0 (en) | 2010-08-25 | 2010-10-06 | Cambridge Entpr Ltd | In vitro hepatic differentiation |
KR101851956B1 (en) | 2010-08-31 | 2018-04-25 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells |
EP2853589B1 (en) | 2010-08-31 | 2017-12-27 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
CN103154237B (en) | 2010-08-31 | 2016-03-16 | 詹森生物科技公司 | The differentiation of multipotential stem cell |
US20120135015A1 (en) | 2010-09-28 | 2012-05-31 | Baylor Research Institute | Induction of Pancreatic Stem Cells by Transient Overexpression of Reprogramming Factors and PDX1 Selection |
EP2508607A1 (en) | 2011-04-07 | 2012-10-10 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for liver regeneration and for treatment of liver failure |
US20120270890A1 (en) * | 2011-04-22 | 2012-10-25 | Cheng-Ho Chung | Methods of Pancreatic Beta Cell Regeneration |
EP2726468B1 (en) | 2011-06-27 | 2017-04-12 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
CA2840013C (en) | 2011-06-27 | 2021-02-09 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
WO2013018851A1 (en) | 2011-08-02 | 2013-02-07 | 独立行政法人国立がん研究センター | Method for inducing hepatic differentiation from induced hepatic stem cell, and induced hepatic progenitor cell |
US20140243374A1 (en) | 2011-10-04 | 2014-08-28 | The Brigham And Women's Hospital, Inc. | Novel Sulfonamides |
DK2768948T3 (en) * | 2011-10-18 | 2017-08-14 | Univercell Biosolutions | PREPARATION OF A HUMAN BETA CELL LINE FROM AN EARLY POSTNATAL ARGUMENT |
CA2855932A1 (en) | 2011-11-13 | 2013-05-16 | Blanchette Rockefeller Neurosciences Institute | Pkc activators and combinations thereof |
BR112014015417A8 (en) | 2011-12-22 | 2017-07-04 | Janssen Biotech Inc | differentiation of human embryonic stem cells into single hormone insulin positive cells |
EP2847319A4 (en) | 2012-05-07 | 2015-12-16 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into pancreatic endoderm |
US9611275B2 (en) | 2012-05-08 | 2017-04-04 | Alectos Therapeutics, Inc. | Permeable glycosidase inhibitors and uses thereof |
WO2013166654A1 (en) | 2012-05-08 | 2013-11-14 | Merck Sharp & Dohme Corp. | Permeable glycosidase inhibitors and uses thereof |
ES2897649T3 (en) | 2012-06-08 | 2022-03-02 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into pancreatic endocrine cells |
KR20150030709A (en) | 2012-06-14 | 2015-03-20 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells into pancreatic endocrine cells |
JP6470687B2 (en) | 2012-09-03 | 2019-02-13 | ノヴォ ノルディスク アー/エス | Production of pancreatic endoderm from pluripotent stem cells using small molecules |
MX2015008619A (en) | 2012-12-31 | 2016-01-12 | Janssen Biotech Inc | Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells. |
CA2896658C (en) * | 2012-12-31 | 2021-06-22 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators |
SG10201709338RA (en) * | 2012-12-31 | 2017-12-28 | Janssen Biotech Inc | Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells |
US11920160B2 (en) | 2013-02-22 | 2024-03-05 | Cedars-Sinai Medical Center | Pancreatic insulin-producing beta-cell lines derived from human pluripotent stem cells |
US20140287944A1 (en) | 2013-02-26 | 2014-09-25 | President And Fellows Of Harvard College | Markers for functionally mature beta-cells and methods of using the same |
KR102334260B1 (en) | 2013-03-14 | 2021-12-02 | 스미토모 다이니폰 파마 온콜로지, 인크. | Jak2 and alk2 inhibitors and methods for their use |
US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
US20140329704A1 (en) | 2013-03-28 | 2014-11-06 | President And Fellows Of Harvard College | Markers for mature beta-cells and methods of using the same |
KR102232650B1 (en) | 2013-06-11 | 2021-03-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
EP3039122B1 (en) | 2013-08-30 | 2019-07-17 | Novo Nordisk A/S | Generation of endocrine progenitor cells from human pluripotent stem cells using small molecules |
EP3954759A1 (en) | 2014-05-16 | 2022-02-16 | Janssen Biotech, Inc. | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
EP3712254A1 (en) | 2014-05-28 | 2020-09-23 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into gastric tissues through directed differentiation |
CA2957000C (en) | 2014-08-04 | 2023-08-01 | Takeda Pharmaceutical Company Limited | Method for proliferation of pancreatic progenitor cells |
US20160175363A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Methods for generating stem cell-derived beta cells and uses thereof |
US10443042B2 (en) | 2014-12-18 | 2019-10-15 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof |
US10253298B2 (en) | 2014-12-18 | 2019-04-09 | President And Fellows Of Harvard College | Methods for generating stem cell-derived beta cells and methods of use thereof |
WO2016100925A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED β CELLS AND USES THEREOF |
EP3234110B1 (en) | 2014-12-18 | 2024-02-28 | President and Fellows of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED ß CELLS AND USES THEREOF |
US9974784B2 (en) | 2015-01-21 | 2018-05-22 | The Texas A&M University System | Inhibitors of activin-like receptor kinases |
-
2014
- 2014-06-11 KR KR1020207036431A patent/KR102232650B1/en active IP Right Grant
- 2014-06-11 CN CN202011023525.9A patent/CN112226402A/en active Pending
- 2014-06-11 CN CN201480045183.7A patent/CN105579577A/en active Pending
- 2014-06-11 GB GB1622354.7A patent/GB2549822B/en active Active
- 2014-06-11 KR KR1020167000699A patent/KR102205234B1/en active IP Right Grant
- 2014-06-11 MX MX2015017103A patent/MX2015017103A/en unknown
- 2014-06-11 EP EP14810778.2A patent/EP3008170A4/en active Pending
- 2014-06-11 RU RU2016100219A patent/RU2016100219A/en not_active Application Discontinuation
- 2014-06-11 SG SG11201510176VA patent/SG11201510176VA/en unknown
- 2014-06-11 CN CN201910284587.6A patent/CN110551678B/en active Active
- 2014-06-11 EP EP14819763.5A patent/EP3008168B1/en active Active
- 2014-06-11 BR BR112015030972A patent/BR112015030972A8/en not_active Application Discontinuation
- 2014-06-11 KR KR1020227024584A patent/KR102631225B1/en active Application Filing
- 2014-06-11 DK DK14819763.5T patent/DK3008168T3/en active
- 2014-06-11 CN CN201480045081.5A patent/CN106414718A/en active Pending
- 2014-06-11 DE DE202014011287.8U patent/DE202014011287U1/en active Active
- 2014-06-11 KR KR1020227004200A patent/KR102423106B1/en active IP Right Grant
- 2014-06-11 GB GB1803318.3A patent/GB2557508B/en active Active
- 2014-06-11 SG SG10201710218RA patent/SG10201710218RA/en unknown
- 2014-06-11 RU RU2016100433A patent/RU2692595C2/en active
- 2014-06-11 JP JP2016519627A patent/JP6514689B2/en active Active
- 2014-06-11 KR KR1020167000634A patent/KR102201638B1/en active IP Right Grant
- 2014-06-11 WO PCT/US2014/041992 patent/WO2014201167A1/en active Application Filing
- 2014-06-11 US US14/898,015 patent/US20170029778A1/en not_active Abandoned
- 2014-06-11 SG SG11201510177WA patent/SG11201510177WA/en unknown
- 2014-06-11 AU AU2014278178A patent/AU2014278178B2/en not_active Withdrawn - After Issue
- 2014-06-11 AU AU2014284677A patent/AU2014284677B2/en active Active
- 2014-06-11 KR KR1020217041325A patent/KR102390167B1/en active IP Right Grant
- 2014-06-11 KR KR1020237012999A patent/KR102580225B1/en active IP Right Grant
- 2014-06-11 WO PCT/US2014/041988 patent/WO2015002724A2/en active Application Filing
- 2014-06-11 CA CA2915088A patent/CA2915088A1/en active Pending
- 2014-06-11 JP JP2016519628A patent/JP6677634B2/en active Active
- 2014-06-11 CA CA2915091A patent/CA2915091A1/en active Pending
- 2014-06-11 DE DE112014002780.4T patent/DE112014002780T5/en active Pending
- 2014-06-11 KR KR1020237031461A patent/KR102640729B1/en active IP Right Grant
- 2014-06-11 BR BR112015030946A patent/BR112015030946A8/en not_active Application Discontinuation
- 2014-06-11 EP EP19179173.0A patent/EP3569694A1/en active Pending
- 2014-06-11 KR KR1020217001204A patent/KR102341674B1/en active IP Right Grant
- 2014-06-11 KR KR1020227013185A patent/KR102523912B1/en active IP Right Grant
- 2014-06-11 KR KR1020217008409A patent/KR102361924B1/en active IP Right Grant
- 2014-06-11 KR KR1020247003026A patent/KR20240014630A/en not_active Application Discontinuation
- 2014-06-11 GB GB1521857.1A patent/GB2531952C/en active Active
-
2015
- 2015-04-10 US US14/684,129 patent/US20150240212A1/en not_active Abandoned
- 2015-04-10 US US14/684,101 patent/US10030229B2/en active Active
- 2015-12-11 PH PH12015502767A patent/PH12015502767A1/en unknown
- 2015-12-11 MX MX2019003616A patent/MX2019003616A/en unknown
-
2018
- 2018-07-23 US US16/042,933 patent/US20190017031A1/en not_active Abandoned
- 2018-07-23 US US16/042,917 patent/US10655106B2/en active Active
- 2018-12-17 HK HK18116147.8A patent/HK1257187B/en unknown
-
2019
- 2019-02-11 US US16/273,076 patent/US20190169575A1/en not_active Abandoned
- 2019-04-12 JP JP2019076519A patent/JP6893527B2/en active Active
-
2020
- 2020-03-13 JP JP2020044320A patent/JP7354026B2/en active Active
- 2020-05-13 AU AU2020203127A patent/AU2020203127C1/en active Active
- 2020-07-21 US US16/934,333 patent/US11078463B2/en active Active
- 2020-07-21 US US16/934,412 patent/US11162078B2/en active Active
- 2020-07-21 US US16/934,503 patent/US11104883B2/en active Active
- 2020-12-14 AU AU2020289721A patent/AU2020289721B2/en active Active
-
2021
- 2021-06-01 JP JP2021091996A patent/JP2021121223A/en active Pending
- 2021-10-29 US US17/514,609 patent/US20220162562A1/en active Pending
-
2022
- 2022-02-11 US US17/670,124 patent/US20220396775A1/en active Pending
- 2022-11-01 US US17/978,936 patent/US11827905B2/en active Active
-
2023
- 2023-04-21 JP JP2023070217A patent/JP2023093654A/en active Pending
- 2023-08-07 US US18/231,208 patent/US20240101963A1/en active Pending
- 2023-09-12 AU AU2023229504A patent/AU2023229504A1/en active Pending
- 2023-09-25 AU AU2023237028A patent/AU2023237028A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273205A (en) | Compositions and methods | |
GB201521857D0 (en) | SC-# cells and compositions and methods for generating the same | |
HK1218837A1 (en) | Compositions and methods | |
HK1218560A1 (en) | Compositions and methods | |
GB2521022B (en) | Compositions and methods | |
IL267283A (en) | Methods and compositions for generating epicardium cells | |
IL265876A (en) | Compositions comprising 15-ohepa and methods of using the same | |
GB201308072D0 (en) | Compositions and methods | |
EP2943591A4 (en) | Methods and compositions for single cell expression profiling | |
GB201305813D0 (en) | Compositions and methods | |
EP2970915A4 (en) | Methods and compositions for generating stable transfected cells | |
GB201322456D0 (en) | Radiotracer compositions and methods | |
EP2964610A4 (en) | Vinylsulfone-based 18f-labeling compositions and methods and uses thereof | |
SG10201802231RA (en) | Methods and compositions for producing hepatocyte-like cells | |
SG11201604904XA (en) | Detergent and rinse-aid compositions and methods | |
EP3001881A4 (en) | Photovoltaic devices and methods for making the same | |
GB201322617D0 (en) | Methods and compositions | |
GB201312393D0 (en) | Compositions and Methods | |
GB201300628D0 (en) | Compositions comprising 15-OHEPA and methods of using the same |